Novel Enzyme-Linked Immunosorbent Assay Systems for the Quantitative Analysis of Connective Tissue Growth Factor (CTGF/Hcs24/CCN2): Detection of HTLV-I Tax-Induced CTGF from a Human Carcinoma Cell Line

DNA and Cell Biology

Volumn 22, Issue 10, 2003, Pages 641-648

  Kawaki, Harumi ^a   Kubota, Satoshi ^a   Minato, Masanao ^a   Moritani, Norifumi H ^a   Hattori, Takako ^a   Hanagata, Hiroshi ^b   Kubota, Mamoru ^c   Miyauchi, Akira ^d   Nakanishi, Tohru ^a   Takigawa, Masaharu ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b Yamasa Shoyu Co Ltd   (Japan)

^c Central Pharmaceutical Research Institute   (Japan)

^d Protein Express Co Ltd   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; HYPERTROPHIC CHONDROCYTE SPECIFIC GENE PRODUCT 24; TAX PROTEIN; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

AMINO TERMINAL SEQUENCE; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL MIGRATION; CELL PROLIFERATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN INDUCTION; PROTEIN PROCESSING; QUANTITATIVE ANALYSIS;

ANTIBODIES, MONOCLONAL; BIOLOGICAL MARKERS; CARCINOMA, SQUAMOUS CELL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GENES, PX; HUMANS; IMMEDIATE-EARLY PROTEINS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MITOGENS; MOUTH NEOPLASMS; TRANSFECTION; TUMOR CELLS, CULTURED;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 0242288070     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/104454903770238111     Document Type: Article

References (29)

1. BORK, P. (1993). The modular architecture of a new family of growth regulators related to connective tissue growth factor. FEBS Lett. 327, 125-130.
2. BRIGSTOCK, D.R. (1999). The connective tissue growth factor/ cysteine-rich 61/nephroblastoma overexpressed (CCN) family. Endocr. Rev. 20, 189-206.
3. BRIGSTOCK, D.R., STEFFEN, C.L., KIM, G.Y., VEGUNTA, R.K., DIEHL, J.R., and HARDING, P.A. (1997). Purification and characterization of novel heparin-binding growth factors in uterine secretory fluids. Identification as heparin-regulated Mr 10,000 forms of connective tissue growth factor. J. Biol. Chem. 272, 20275-20282.
4. BRUNNER, A., CHINN, J., NEUBAUER, M., and PURCHIO, A.F. (1991). Identification of a gene family regulated by transforming growth factor-beta. DNA Cell Biol. 10, 293-300.
5. CHEN, C.C., CHEN, N., and LAU, L.F. (2001). The angiogenic factors Cyr61 and connective tissue growth factor induce adhesive sig-naling in primary human skin fibroblasts. J. Biol. Chem. 276, 10443-10452.
6. CHEN, N., CHEN, C.C., and LAU, L.F. (2000). Adhesion of human skin fibroblasts to Cyr61 is mediated through integrin α6β and cell surface heparan sulfate proteoglycans. J. Biol. Chem. 275, 24953-24961.
7. EGUCHI, T., KUBOTA, S., KONDO, S., SHIMO, T., HATTORI, T., NAKANISHI, T., KUBOKI, T., YATANI, H., and TAKIGAWA, M. (2001). Regulatory mechanism of human connective tissue growth factor (CTGF/Hcs24) gene expression in a human chondrocytic cell line, HCS-2/8. J. Biochem. 130, 79-87.
8. GROTENDORST, G.R. (1997). Connective tissue growth factor: A mediator of TGF-beta action on fibroblasts. Cytokine Growth Factor Rev. 8, 171-179.
9. HISHIKAWA, K., NAKAKI, T., and FUJII, T. (1999). Transforming growth factor-beta(1) induces apoptosis via connective tissue growth factor in human aortic smooth muscle cells. Eur. J. Pharmacol. 385, 287-290.
10. IGARASHI, A., NASHIRO, K., KIKUCHI, K., SATO, S., IHN, H, GROTENDORST, G.R., and TAKEHARA, K. (1995). Significant correlation between connective tissue growth factor gene expression and skin sclerosis in tissue sections from patients with systemic sclerosis. J. Invest. Dermatol. 105, 280-284.
11. KASUGA, H., ITO, Y., SAKAMOTO, S., KAWACHI, H., SHIMIZU, F., YUZAWA, Y., and MATSUO, S. (2001). Effects of anti-TGF-beta type II receptor antibody on experimental glomerulonephritis. Kidney Int. 60, 1745-1755.
12. KONDO, S., KUBOTA, S., SHIMO, T., NISHIDA, T., YOSIMICHI, G., EGUCHI, T., SUGAHARA, T., and TAKIGAWA, M. (2002). Connective tissue growth factor increased by hypoxia may initiate angiogenesis in collaboration with matrix metalloproteinases. Carcinogenesis 23, 769-776.
13. KUBOTA, S., EGUCHI, T., SHIMO, T., HATTORI, T., KONDO, S., NAKANISHI, T., and TAKIGAWA, M. (2001). Novel mode of processing and secretion of connective tissue growth factor (CTGF/Hcs24) in chondrocytic HCS-2/8 cells. Bone 29, 155-161.
14. LAU, L.F., and LAM, S.C. (1999). The CCN family of angiogenic regulators: The integrin connection. Exp. Cell Res. 248, 44-57.
15. MORITANI, N.H., KUBOTA, S., NISHIDA, T., KAWAKI, H., KONDO, S., SUGAHARA, T., TAKIGAWA, M. (2003). Suppressive effect of overexpressed connective tissue growth factor on tumor cell growth in a human oral squamous cell carcinoma-derived cell line. Cancer Lett. 192, 205-214.
16. NAKANISHI, T., NISHIDA, T., SHIMO, T., KOBAYASHI, K., KUBO, T., TAMATANI, T., TEZUKA, K., and TAKIGAWA, M. (2000). Effects of CTGF/Hcs24, a product of a hypertrophic chondrocyte-specific gene, on the proliferation and differentiation of chondrocytes in culture. Endocrinology 141, 264-273.
17. NISHIDA, T., NAKANISHI, T., ASANO, M., SHIMO, T., and TAKIGAWA, M. (2000). Effects of CTGF/Hcs24, a hypertrophic chondrocyte-specific gene product, on the proliferation and differentiation of osteoblastic cells in vitro. J. Cell. Physiol. 184, 197-206.
18. OEMAR, B.S., WERNER, A., GARNIER, J.M., DO, D.D., GODOY, N., NAUCK, M., MARZ, W., RUPP, J., PECH, M., and LUSCHER, T.F. (1997). Human connective tissue growth factor is expressed in advanced atherosclerotic lesions. Circulation 95, 831-839.
19. PERBAL, B. (2001). NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues. Mol. Pathol. 54, 57-79.
20. RYSECK, R.P., MacDONALD-BRAVO, H., MATTEI, M.G., and BRAVO, R. (1991). Structure, mapping, and expression of fisp-12, a growth factor-inducible gene encoding a secreted cysteine-rich protein. Cell Growth Differ. 2, 225-233.
21. SHIMO, T., NAKANISHI, T., KIMURA, Y., NISHIDA, T., ISHIZEKI, K., MATSUMURA, T., and TAKIGAWA, M. (1998). Inhibition of endogenous expression of connective tissue growth factor by its antisense oligonucleotide and antisense RNA suppresses proliferation and migration of vascular endothelial cells. J. Biochem. (Tokyo) 124, 130-140.
22. STEFFEN, C.L., BALL-MIRTH, C.K., HARDING, P.A., BHATTACHARYYA, N., PILLAI, S., and BRIGSTOCK, D.R. (1998). Characterization of cell-associated and soluble forms of connective tissue growth factor (CTGF) produced by fibroblast cells in vitro. Growth Factors 15, 199-213.
23. TAKIGAWA, M., NAKANISHI, T., KUBOTA, S., and NISHIDA, T. (2003). Role of CTGF/Hcs24/Ecogenin in skeletal growth control. J. Cell. Physiol. 194, 256-266.
24. TAMATANI, T., KOBAYASHI, H., TEZUKA, K., SAKAMOTO, S., SUZUKI, K., NAKANISHI, T., TAKIGAWA, M., and MIYANO, T. (1998). Establishment of the enzyme-linked immunosorbent assay for connective tissue growth factor (CTGF) and its detection in the sera of biliary atresia. Biochem. Biophys. Res. Commun. 251, 748-752.
25. TANAKA, A., TAKAHASHI, C., YAMAOKA, S., NOSAKA, T., MAKI, M., and HATANAKA, M. (1990). Oncogenic transformation by the tax gene of human T-cell leukemia virus type I in vitro. Proc. Natl. Acad. Sci. USA 87, 1071-1075.
26. WAHAB, N.A., YEVDOKIMOVA, N., WESTON, B.S., ROBERTS, T., LI, X.J., BRINKMAN, H., and MASON, R.M. (2001). Role of connective tissue growth factor in the pathogenesis of diabetic nephropathy. Biochem. J. 359, 77-87.
27. WENGER, C., ELLENRIEDER, V., ALBER, B., LACHER, U., MENKE, A., HAMEISTER, H., WILDA, M., IWAMURA, T., BEGER, H.G., ADLER, G., et al. (1999). Expression and differential regulation of connective tissue growth factor in pancreatic cancer cells. Oncogene 18, 1073-1080.
28. XIE, D., NAKACHI, K., WANG, H., ELASHOFF, R., and KOEFFLER, H.P. (2001). Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features. Cancer Res. 61, 8917-8923.
29. YAMADA, S., IKEDA, H., YAMAZAKI, SHIKISHIMA, H., KIKUCHI, K., WAKISAKA, A., KASAI, N., SHIMOTOHNO, K., and YOSHIKI, T. (1995). Cytokine-producing mammary carcinomas in transgenic rats carrying the pX gene of human T-lymphotropic virus type I. Cancer Res. 55, 2524-2527.